Proactive cardiovascular risk management versus usual care in patients with and without diabetes mellitus: CRUCIAL trial subanalysis.

about

Proactive cardiovascular risk management versus usual care in patients with and without diabetes mellitus: CRUCIAL trial subanalysis.

Item

http://www.wikidata.org/entity/Q38465532

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Proactive cardiovascular risk ...... us: CRUCIAL trial subanalysis.

@en

type

Item

label

Proactive cardiovascular risk ...... us: CRUCIAL trial subanalysis.

@en

prefLabel

Proactive cardiovascular risk ...... us: CRUCIAL trial subanalysis.

@en

P1476

Proactive cardiovascular risk ...... us: CRUCIAL trial subanalysis.

@en

P2093

Abel Pavia

http://www.w3.org/2001/XMLSchema#string

Ayman Al-Khadra

http://www.w3.org/2001/XMLSchema#string

CR UCIAL Investigators

http://www.w3.org/2001/XMLSchema#string

Carla Yunis

http://www.w3.org/2001/XMLSchema#string

Jae-Hyung Kim

http://www.w3.org/2001/XMLSchema#string

José Zamorano

http://www.w3.org/2001/XMLSchema#string

Santosh Sutradhar

http://www.w3.org/2001/XMLSchema#string

Serap Erdine

http://www.w3.org/2001/XMLSchema#string

P2860

Prediction of Coronary Heart Disease Using Risk Factor Categories

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Global estimates of the prevalence of diabetes for 2010 and 2030

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association.

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial.

P304

41-53

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3810/PGM.2012.07.2565

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

124

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22913893

http://www.w3.org/2001/XMLSchema#string